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ABSTRACT
Objectives: To study the associations of pre-stroke
cognitive performance with mortality after ﬁrst-ever
stroke or transient ischaemic attack (TIA).
Design: A prospective cohort study.
Setting and participants: In participants having ﬁrst-
ever stroke or TIA during up to 14 years of post-test
follow-up (n¼155), we investigated the associations of
pre-stroke variables and cognitive test results with
post-stroke survival. The study is based on those
participants of the Uppsala Longitudinal Study of Adult
Men who performed cognitive function tests at
approximately age 70 (n¼919).
Primary outcome measures: Mortality after ﬁrst-
ever stroke or TIA related to pre-stroke executive
performance.
Results: Eighty-four (54%) of the ﬁrst-ever stroke/TIA
patients died under a median follow-up of 2.5 years
after the event. In Cox proportional hazard analyses
adjusting for age, education, social group and
traditional stroke risk factors, poor performance in
Trail Making Test (TMT)-A was related to mortality (HR
1.88 per SD, 95% CI 1.31 to 2.71, p¼0.001). The risk
of mortality was approximately threefold higher in the
highest tertile compared with the lowest tertile (HR
TMT-A¼ 2.90 per SD, 95% CI 1.24 to 6.77, p¼0.014).
A similar pattern was seen for TMT-B, but Mini-Mental
State Examination results were not related to risk of
post-stroke mortality.
Conclusion: Executive performance measured by
TMT-A and -B before stroke was independently
associated with long-term risk of mortality, after ﬁrst-
ever stroke or TIA in a population-based study of older
men.
INTRODUCTION
In recent years, stroke seems to have become
a less severe disease.
1 Several authors have
studied prognostic factors for mortality and
dependency after stroke in attempts to iden-
tify and intervene with risk factors deter-
mining the stroke outcome. Well-deﬁned
prediction models of outcome could also
have important implications in clinical prac-
tice in guiding the management and
improving information to patients and rela-
tives. It is well established that high age and
severe impairment predict a poor outcome
after a stroke. Other known prognostic
factors for 30-day survival include cardiac
failure, level of consciousness and grade of
impairment.
2 Appelros et al performed one
of the few population-based studies on this
matter, and their study also took into account
pre-stroke conditions. In their cohort in
O ¨ rebro, Sweden (n¼377) followed up for
1 year post-stroke, heart disease and
dementia were found to have predictive
power for mortality and morbidity.
34Pre-
stroke risk factors for stroke severity need to
be studied in greater detail and with longer
follow-up.
In earlier studies of the cohort partici-
pating in the Uppsala Longitudinal Study of
Adult Men (ULSAM), we observed that
besides traditional stroke risk factors,
performance in the cognitive test Trail
Making Test (TMT)-B at age 70 carried
important information as a predictor of later
incidence of stroke, especially brain infarc-
tion (BI).
5 A poor result in the latter test is
believed to represent subclinical cognitive
deﬁcits due to silent cerebrovascular disease.
6
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Open Access ResearchIn the present study, we addressed the question whether
cognitive function measured with TMT-A and -B and the
Mini-Mental State Examination (MMSE) in the pre-
stroke setting were associated with risk of mortality after
ﬁrst-ever stroke. These questions were investigated in an
extensively characterised community-based sample of 70-
year-old men followed for up to 14 years through registry
data from the Swedish National Board of Health and
Welfare and discharge records.
METHODS
Study sample
The study was based on the ULSAM cohort (http://www.
pubcare.uu.se/ULSAM) participating in a health inves-
tigation focusing on identiﬁcation of metabolic risk
factors for cardiovascular disease, to which all 50-year-old
men living in Uppsala, Sweden, in 1970e1974 were
invited. The ULSAM originally comprised 2322 partici-
pants (82% of the invited). A re-investigation was
performed around 20 years later between 1991 and
1995. Of the 1681 participants available who were invited
to that investigation, 1221 (73%) attended. Seventy-eight
participants were excluded because of a history of
stroke/transient ischaemic attack (TIA) before the
investigation and eight because of misdiagnosis in the
registry, rendering 1135 men eligible. In subsequent
tests of cognitive function performed in 1993e1996, 930
of the eligible participants took part. After additional
exclusion of 11 participants who had had a stroke/TIA
between the baseline examination and the cognitive
testing, 919 were available for the present study. All
medical records from the hospitalisation of those
suffering a ﬁrst-ever stroke/TIA were reviewed by one
physician (BW).
In the whole ULSAM cohort based on the investiga-
tion at age 50 (n¼2322), 232 men had experienced
a ﬁrst stroke and 586 had died, before the planned date
of cognitive function tests.
Clinical examinations
The ULSAM examinations have previously been
described in detail.
7 8 The baseline investigation for the
present study was performed when the participants were
69e75 years old and included a medical questionnaire
concerning previous diseases, alcohol habits and medical
treatment. The participants were physically examined,
including anthropometric measurements. Supine blood
pressure was measured under standardised conditions.
Hypertension was deﬁned as a supine blood pressure of
140/90 mm Hg or higher and/or treatment with anti-
hypertensive drugs. Blood samples were drawn in the
morning after an overnight fast. Cholesterol concentra-
tions were measured in serum by enzymatic techniques
using IL test cholesterol Trinder’s Method for use in
a Monarch apparatus (Instrumentation Laboratories,
Lexington, KT, USA). High-density lipoprotein particles
were separated by precipitation with magnesium chlo-
ride/phosphotungstate. Diabetes was deﬁned according
to the 1997 criteria of American Diabetes Association.
9 A
standard 12-lead ECG was recorded. The revised
Minnesota code was used for classiﬁcation,
10 11 and left
ventricular hypertrophy (LVH) was deﬁned as high-
amplitude R-waves together with a left ventricular strain
pattern. The coding of education was as follows: (1)
elementary school only (6e8 years), (2) secondary
school (12 years) and (3) 3 or more years of college or
graduate examination. The coding of smoking and social
group classiﬁcation was based on interview reports. The
three conventional social classes were used and classiﬁed
in accordance with the Central Bureau of Statistics.
12
Cognitive function tests
In TMT-A, the participant is asked to draw lines with
a pencil between numbers in ascending order, as fast as
possible.
13 In TMT-B, letters are also added, and the task
is to alternate between letters and numbers in ascending
order. The score is equal to the time taken to complete
the test, in seconds. The standard TMT-A consists of
digits 1e25 and TMT-B consists of digits and letters (1-A-
2-B- . -K-12-L-13). The maximum time set for TMT-B
was 240 s, and 41 participants reached that level. A long
completion time reﬂects impaired psychomotor speed.
The MMSE
14 is a screening test for dementia and
cognitive decline and is widely used both in clinical
practice and in research. It has the advantage of being
easy to administer and has a high replicability, but from
clinical practice, it is known to only give a limited
information of cognitive performance in the patients
with stroke. The scores range from 0 (worst) to 30 (best).
MMSE was added to the test battery after the start, and
thus, the number of participants is slightly smaller than
in the other cognitive tests. The cognitive examinations
have been described earlier in detail.
5
Follow-up
The sample was followed up from the ﬁrst investigation
at age 70, that is, from August 1991eMay 1995 to 31
December 2006. None of the subjects was lost to follow-up.
End point
Stroke/TIA and survival were recorded on the bases of
the Swedish Hospital Discharge Record and Cause of
Death Registries and validated by examination of all the
medical records by one physician (BW). The stroke cases
investigated in the present study were as follows:
1. Fatal or non-fatal stroke or TIA (ICD-9 codes 430e31
and 434e436, ICD-10 codes I60e61, I63.0eI63.5,
I63.8e9, I64 and G45).
2. Fatal or non-fatal BI (ICD-9 code 434; ICD-10 codes
I63.0eI63.5 and I63.8e9). The end points were
mortality after a ﬁrst-ever stroke/TIA-event.
Statistical methods
Distributions were tested for normality by the Shapiroe
Wilk W test, and logarithmic transformation was
performed when necessary to obtain normality (TMT-A
and -B). The prognostic value of a 1SD increase in the
continuous variables or transfer from one level to
another of the dichotomous variables was investigated
2 Wiberg B, Kilander L, Sundstro ¨m J, et al. BMJ Open 2012;2:e000458. doi:10.1136/bmjopen-2011-000458
Executive dysfunction prior to strokewith Cox proportional HRs. Four MMSE groups as equal
in size as possible were considered (#27, 28, 29 and 30
points). Interaction terms between all baseline covariates
were examined, and no evidence of effect modiﬁcation
was found. We examined three sets of models in a hier-
archical fashion:
1. Models A adjusting for age at baseline.
2. Models B adjusting for age, education and social
group at baseline.
3. Models C adjusting for the following baseline cova-
riates: age, education, social group, systolic blood
pressure, hypertension treatment, serum cholesterol,
diabetes mellitus, atrial ﬁbrillation, ECG-LVH and
current smoking.
Proportional hazards assumptions were conﬁrmed
graphically and by Schoenfeld’s test. Two-tailed 95% CIs
and p values were given, with p<0.05 regarded as
signiﬁcant.
KaplaneMeier curves for TMT-A and -B in tertiles were
used for survival estimates. Authors BW and LB
performed all statistical analyses, using Stata V.10.1
(Stata Corporation).
RESULTS
Characteristics from the examination at age 70 years are
presented in table 1. The mortality incidence rate
among the 155 subjects with stroke/TIA was 148/1000
person-years at risk (PYAR) (84 deaths during 566
PYAR). The median follow-up to the ﬁrst stroke/TIA
event was 11.2 years (maximum 13.6 years), and the
median follow-up after ﬁrst-ever stroke/TIA was 2.5 years
(maximum 12.2 years), contributing to 566 PYAR. A total
of 84 men died during the time of follow-up (54%), of
which 22 died within 1 month (14%) and 42 within
1 year (27%). The diagnoses were BI in 97 cases, intra-
cerebral haemorrhage in 24 cases and the rest being
TIA, unspeciﬁed stroke or subarachnoid haemorrhage.
Of those suffering a BI, 53 died during follow-up.
Relations of baseline variables at age 70 to the ﬁrst-ever
stroke mortality up to the end of follow-up are presented
in table 2. In Cox proportional hazard models adjusting
for age at baseline, the prevalence of ECG-LVH, diabetes
and treatment with antihypertensives at baseline were
strongly related to death after ﬁrst-ever stroke. This was
also true when the subgroup of BIs was analysed in all
models (eg, HR 2.40, 95% CI 1.24 to 4.66 for ECG-LVH
prevalence and HR 2.01, 95% CI 1.06 to 3.80 for diabetes
prevalence in models C). No other investigated variable
showed any signiﬁcant relation to mortality in the total
stroke sample or in the subgroup of BIs in these analyses
except for treatment with lipid lowering in the subgroup
of BIs.
Both TMT-A and -B strongly predicted survival in Cox
proportional hazard analyses, but no signiﬁcant relation
Table 1 Baseline characteristics at age 70
All participants
(n[919)
Participants with
stroke/TIA (n[155)
Systolic blood pressure (mm Hg) 146 (18) 151 (19)
S-total cholesterol (mmol/l) 5.8 (1.0) 5.9 (1.1)
Atrial ﬁbrillation 36 (4%) 9 (10%)
ECG-LVH 65 (7%) 14 (16%)
Hypertension prevalence 676 (74%) 82 (84%)
Diabetes prevalence 159 (17%) 21 (22%)
Treatment with hypertension medicine 306 (33%) 44 (45%)
Treatment with diabetes medicine 48 (5%) 7 (7%)
Treatment with lipid-lowering medicine 80 (9%) 14 (16%)
Current cigarette smoking 174 (19%) 23 (24%)
Education
Elementary school only (7 or 8 years) 571 (81%) 53 (74%)
Secondary school (12 years) 51 (7%) 8 (11%)
Three or more years of college or graduate examination 107 (15%) 11 (15%)
Social group
Low 388 (42%) 39 (40%)
Middle 361 (39%) 36 (37%)
High 169 (18%) 22 (23%)
Mini-Mental State Examination
Group #27 points 182 (22%) 21 (24%)
Group 28 points 181 (22%) 20 (23%)
Group 29 points 264 (32%) 27 (31%)
Group 30 points 192 (23%) 18 (21%)
Trail Making Test-A (seconds) 47 (20) 48 (20)
Trail Making Test-B (seconds) 119 (48) 127 (46)
Data are presented as means (SDs) or numbers of individuals (%).
Diabetes is deﬁned according to the 1997 American Diabetes Association criteria.
LVH, left ventricular hypertrophy; S, serum; TIA, transient ischaemic attack.
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Executive dysfunction prior to strokebetween MMSE scores and future mortality was seen
(table 3).
KaplaneMeier survival estimates for TMT-A by tertiles
are displayed in ﬁgure 1 and for TMT-B by tertiles in
ﬁgure 2. The survival decreased gradually with higher
tertiles.
Incidence rates were similar in stratiﬁed analyses by
tertiles of the independent variables, suggesting no
major deviation from linearity (data not shown).
DISCUSSION
In this community-based sample of elderly men, free
from stroke/TIA at baseline, pre-stroke executive func-
tion, as measured by TMT-A and -B, predicted survival
independent of education, social group and traditional
stroke risk factors, as described in previous studies,
15e18
whereas MMSE had no predictive power in this respect.
Failure in our study to detect association to MMSE could
be explained by a good general cognitive performance.
As no one in the sample had a MMSE score <21 points
and the median score was 29 points, our sample repre-
sents a non-demented population.
In a systematic review article validating prognostic
models by Counsell et al, cardiac failure, level of
consciousness and grade of impairment were the
predictors of survival after 30 days in patients with
stroke. Pre-stroke overt dementia has previously been
observed to be a predictor for initial stroke severity and
28-day and 1-year case death.
3 41 9Patients with small-
vessel disease have an augmented risk of death after
a stroke event.
20As poor performance in TMT-A and -B
in a non-demented population may be interpreted as
impaired subcortical function, our ﬁndings regarding
survival point in the same direction. The present study is
unique in its kind since the cognitive function evaluation
was performed up to 12 years before the stroke event.
Executive dysfunction in an elderly population may be
a manifestation of clinically unrealised cerebrovascular
disease
21 and seems to be an objective in small vessel
disease.
22 Lines of research suggest associations between
vascular risk factors, such as age, hypertension, smoking
and glucometabolic disturbances,
23e26 and brain
atrophy, white matter abnormalities and silent cerebral
infarctions.
62 7 e29 These vascular risk factors could be
the cause of brain lesions, not yet recognised clinically,
and earlier studies have shown associations between
cerebrovascular risk factor burden and a broad range of
cognitive abilities.
30 31 Ischaemic small vessel disease is
recently underlined as a potentially severe condition
prodrome of subcortical vascular dementia.
20
Biological ageing of the brain is partly attributable to
ageing of the cerebrovascular circulation and effects of
these vascular changes on the brain.
32 33Mid-life stroke
risk factors have been related to late-life cognitive
impairment. The importance of managing stroke risk
factors is further reinforced by the inverse association
between global atrophy measured with MRI and results
from cognitive testing.
31
Earlier cross-sectional studies on the ULSAM cohort
have also demonstrated that high 24-h BP, non-dipping,
Table 2 Relations of baseline clinical variables to mortality after ﬁrst-ever stroke
All stroke/TIA (n[155),
84 died during follow-up
Brain infarction (n[97),
53 died during follow-up
Adjusted for age at baseline
models A
Adjusted for age at baseline
models A
Systolic blood pressure (mm Hg) 1.00 (0.99 to 1.02) 1.00 (0.98 to 1.01)
p¼0.418 p¼0.730
S-total cholesterol (mmol/l) 0.85 (0.69 to 1.04) 0.88 (0.66 to 1.17)
p¼0.122 p¼0.384
Atrial ﬁbrillation 1.14 (0.56 to 2.29) 0.54 (0.20 to 1.43)
p¼0.722 p¼0.216
ECG-LVH 1.88 (1.04 to 3.39) 2.54 (1.25 to 5.15)
p¼0.035 p¼0.010
Hypertension prevalence 1.19 (0.64 to 2.20) 1.66 (0.74 to 3.71)
p¼0.576 p¼0.217
Diabetes prevalence 1.67 (1.04 to 2.69) 1.85 (1.00 to 3.41)
p¼0.035 p¼0.050
Treatment with antihypertensives 1.56 (1.02 to 2.40) 2.60 (1.50 to 4.50)
p¼0.042 p¼0.001
Treatment with antidiabetics 1.28 (0.71 to 2.39) 1.48 (0.58 to 3.77)
p¼0.514 p¼0.410
Treatment with lipid-lowering medicine 1.53 (0.83 to 2.84) 2.17 (1.01 to 4.65)
p¼0.173 p¼0.046
Current cigarette smoking 0.97 (0.56 to 1.69) 1.05 (0.54 to 2.04)
p¼0.921 p¼0.885
Data are presented as Cox proportional HRs (95% CI) for a 1SD increase in the continuous variables or transfer from one level to another of the
dichotomous variables.
LVH, left ventricular hypertrophy; S, serum; TIA, transient ischaemic attack.
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Executive dysfunction prior to strokeinsulin resistance and diabetes were all related to low
cognitive function.
33 Our own earlier studies on this
cohort indicated that the risk of BI was increased in men
with poor TMT-B test results.
5
Remarkable in this study, as the risk of stroke/TIA
related to TMT-A and -B scores increase when adjusting
for education and social factors (models B) and further
in the multivariable-adjusted model (models C), is that
the risk related to the tests seem to exist separately,
beside the track of traditional stroke risk factors.
Our study has strengths. It is based on a large
community-based sample, and it has a long follow-up
with a large number of persons with incident stroke,
non-existent loss to follow-up and extensive information
on traditional risk factors, reducing the risk of
confounding. All stroke and TIA cases have been
examined in detail through medical records. The sample
is also representative of the general population in
Sweden regarding stroke incidence, according to data
published by the Swedish National Board of Health and
Welfare (http://www.sos.se/sosmeny.htm). The accuracy
of the Swedish Hospital Discharge Record and the Cause
of Death Registries has been shown to be high regarding
stroke diagnosis.
34 Limitations include an unknown
generalisability to women and to other age and ethnic
groups, as only men of similar age and ethnic back-
ground were examined. The present cohort has been
re-examined a few times since baseline and risk factors
have been treated and the men of the cohort may
therefore have been healthier during follow-up than the
average man of the same age. It is unlikely, however, that
this would have inﬂuenced the associations we have
demonstrated in our study.
Regarding TMT-A and -B, it has been suggested that
the difference between the two tests might be a more
pure measure of executive function independent from
individual differences in psychomotor speed.
35 However,
creating a difference or a ratio may also introduce bias in
the estimate and increases the measurement error why
we chose not to.
Pre-stroke cognitive performance measured with TMT-
A and -B in a population-based study strongly predicted
post-stroke mortality independent of education, socio-
economic status or traditional risk factors. Thus, TMT-A
and -B, easily accessible cognitive tests for clinical use,
may not only be used as tools for identifying risk of
stroke but may also be considered important predictors
of post-stroke mortality.
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